AtriCure | ATRC - Current Liabilities

Stock Price
31.98
Daily Change
-0.60 -1.84%
Monthly
-16.96%
Yearly
-18.40%
Q1 Forecast
31.57

AtriCure reported $81.52M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Artivion USD 85.84M 19.17M Sep/2025
AtriCure USD 81.52M 3.68M Dec/2025
Baxter International USD 2.97B 805M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Boston Scientific USD 5.44B 111M Dec/2025
Cooper Companies USD 1.11B 102.7M Sep/2025
Dexcom USD 2.14B 1.19B Dec/2025
Edwards Lifesciences USD 1.59B 183.3M Sep/2025
Globus Medical USD 465.96M 41.29M Sep/2025
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 680.1M 32.4M Dec/2025
Integra LifeSciences USD 364.05M 565.75M Sep/2025
Intuitive Surgical USD 2.52B 207.3M Dec/2025
J&J USD 54.13B 3.26B Dec/2025
Masimo USD 369.7M 222.4M Sep/2025
Medtronic USD 9.94B 1.6B Sep/2025
Merit Medical Systems USD 230.48M 4.9M Sep/2025
ResMed USD 1.25B 7.39M Dec/2025
Stryker USD 7.79B 380M Dec/2025
Tandem Diabetes Care USD 242.72M 9.82M Dec/2025
Teleflex USD 773.03M 56.88M Sep/2025
Zimmer Biomet Holdings USD 2.58B 180.8M Dec/2025